Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Archive
- 2026/Volume 47
- 2025/Volume 46
- 2024/Volume 45
- 2023/Volume 44
- 2022/Volume 43
- 2021/Volume 42
- 2020/Volume 41
- 2019/Volume 40
- 2018/Volume 39
- 2017/Volume 38
- 2016/Volume 37
- 2015/Volume 36
- 2014/Volume 35
- 2013/Volume 34
- 2012/Volume 33
- 2011/Volume 32
- 2011/Volume 31
- 2009/Volume 30
- 2008/Volume 29
- 2007/Volume 28
- 2006/Volume 27
- 2005/Volume 26
- 2004/Volume 25
- 2003/Volume 24
- 2002/Volume 23
- 2001/Volume 22
- 2000/Volume 21
Vol.43,Issue 5,October 2022
Reviews
Progress in therapeutic HPV vaccines: observations from clinical trials
Progress in therapeutic HPV vaccines: observations from clinical trials
DOI: 10.22514/ejgo.2022.038
Original Research
DNAJB5 (hsc40) gene as a novel biomarker for cervical cancer
DNAJB5 (hsc40) gene as a novel biomarker for cervical cancer
DOI: 10.22514/ejgo.2022.023
Salvage chemotherapy and maintenance therapy with poly adenosine diphosphate-ribose polymerase inhibitors for bevacizumab-resistant relapse of epithelial ovarian cancer
Salvage chemotherapy and maintenance therapy with poly adenosine diphosphate-ribose polymerase inhibitors for bevacizumab-resistant relapse of epithelial ovarian cancer
DOI: 10.22514/ejgo.2022.040
(This article belongs to the Special Issue Topic Collection "Current Novel Treatment of Patients with Ovarian Cancer")
Estrogen receptor 1 and Aurora kinase A as potential diagnostic biomarkers for cervical cancer
Estrogen receptor 1 and Aurora kinase A as potential diagnostic biomarkers for cervical cancer
DOI: 10.22514/ejgo.2022.025
A retrospective study of 657 women with vaginal intraepithelial neoplasia (VaIN)
A retrospective study of 657 women with vaginal intraepithelial neoplasia (VaIN)
DOI: 10.22514/ejgo.2022.041
Comprehensive analysis of STAT family members as prognostic markers in human breast cancer
Comprehensive analysis of STAT family members as prognostic markers in human breast cancer
DOI: 10.22514/ejgo.2022.043
Nomograms for predicting the survival rate of stage T1−T2 uterine cervical adenocarcinoma patients after hysterectomy
Nomograms for predicting the survival rate of stage T1−T2 uterine cervical adenocarcinoma patients after hysterectomy
DOI: 10.22514/ejgo.2022.044
COL12A1 as a prognostic biomarker in HER2-enriched breast cancer and its association with immune infiltration
COL12A1 as a prognostic biomarker in HER2-enriched breast cancer and its association with immune infiltration
DOI: 10.22514/ejgo.2022.045
Fertility-sparing treatments decision in patients with endometrial cancer based on machine learning
Fertility-sparing treatments decision in patients with endometrial cancer based on machine learning
DOI: 10.22514/ejgo.2022.046
Case Reports
Recurrence of low-grade serous ovarian cancer successfully treated with Gemcitabine and Bevacizumab: a case report and literature review
Recurrence of low-grade serous ovarian cancer successfully treated with Gemcitabine and Bevacizumab: a case report and literature review
DOI: 10.22514/ejgo.2022.049
(This article belongs to the Special Issue Gynecological Oncology Treatment: Recent Progress in Clinical Modalities)
Meeting Abstracts
Seminar of Gynecological Oncology of the International Conference on Psychiatry and Neurorestoratology (ICPN2022)
Seminar of Gynecological Oncology of the International Conference on Psychiatry and Neurorestoratology (ICPN2022)
DOI: 10.22514/ejgo.2022.050